South Slope Pediatrics | Brooklyn Pediatrician Dr. Hai Cao, MD
  • Expecting? Book a Free Meet & Greet
  • 718.576.2450
  • SSP NEWS
  • Meet The Doctors + Team
  • Patient Portal
  • SSP Culture
  • SSP 4 Good
  • SSP Blog
  • Free SSP Classes
  • SSP LIVE Updates
  • Insurance
  • FAQs
  • Contact
  • SSP Jobs

South Slope Pediatrics Blog

interview with jill woods, the ultimate super mom

6/20/2016

0 Comments

 
Picture
SSP: How did Jonah’s Just Begun come to be?
Jonah was born July 30th, 2008, happy and healthy. Jeremy and I couldn’t take our eyes off of our remarkable son.

At Jonah’s first-year well visit our astute pediatrician, Dr. Hai Cao, suggested we get Jonah an MRI. Dr. Cao noted that the size of Jonah’s head was “off the charts.” Nine months later, Jeremy and I received news that changed our lives a second time: Jonah had Sanfilippo Type C, a rare disease that is both fatal and incurable.
Love doesn’t falter for your child after a horrific diagnosis. If anything it grows stronger. From that point forward, we understood that every second with our son was precious. We no longer take any family time spent together for granted. http://jonahsjustbegun.org/
Jonah is 8 now and finishing up 2nd grade at ps10. He still has no idea that he’s sick and we plan to keep it that way.



SSP:  What exactly is Sanfilippo and how are children affected?
Sanfilippo Syndrome is caused by a defect in a single cell. It is an inherited disease of metabolism that means the body cannot properly break down long chains of sugar molecules called mucopolysaccharides or glycosaminoglycans (aka GAGs). Sanfilippo syndrome belongs to a group of diseases called mucopolysaccharidoses (MPS). Specifically, it is known as MPS III.
Sanfilippo Syndrome occurs when the enzymes the body needs to break down the Heparan Sulfate (HS) are absent or are defective. When HS is not broken down, the body does not release it. Instead, it is stored inside the lysosomes of every cell in the body.


To date there are four types of Sanfilippo syndrome. They are distinguished by the enzyme that is affected.
  • Sanfilippo Type A: heparan N-sulfatase. Estimated incident rate is 1 in 100,000 live births.
  • Sanfilippo Type B: alpha-N-acetylglucosaminidase. Estimated incident rate is 1 in 200,000 live births.
  • Sanfilippo Type C: acetyl-CoAlpha-glucosaminide acetyltransferase. Estimated incident rate is 1 in 1,400,000.
  • Sanfilippo Type D: N-acetylglucosamine 6-sulfatase. Estimated incident rate is 1 in 1,100,000.

Between the four types of Sanfilippo, the syndrome present in approximately 1 in 70,000 births.


SSP: What happens to a child with Sanfilippo Syndrome?
Sanfilippo is an insidious disease that often goes undetected for years. Most children are born with no visible signs that anything is wrong. It’s not until the preschool years that children start to show cognitive delays or course facial features; even then, the disease is often misdiagnosed.


Sanfilippo is progressive and can be broken down into stages.
First stage: The affected child will display delayed speech as well as mild facial abnormalities and behavioral issues. Some children will exhibit a large head, prominent forehead, bushy eyebrows, coarse hair, thick skin, short neck, full lips, low thick ears, a wide flat nose and full round bellies. Their facial features are described as “coarse.” Affected children are prone to sinus and ear infections, diarrhea, and tight Achilles tendons. Minor bone deformities are quite common.


Second stage: The affected child will become extremely active, restless, suffer sleeplessness and exhibit difficult or ‘quirky’ behavior.  Over time, speech and communication skills decline along with other cognitive and motor skills.


Third stage: The disease will take its ultimate toll. The child will lose the ability to walk, talk and eat on his own while his body shuts down. Depending on the phenotype of the disease, death can occur as early as three years or as late as 30 years old.


Currently there is no cure for Sanfilippo Syndrome. In most cases, treatment is limited to reducing or controlling the symptoms of this disorder by making sure that neurologists, ophthalmologists, cardiologists, ENTs, orthopediatricians, dentists and genetic counselors are consulted routinely.


SSP: How rare (or ultra-rare) is this disease and is there a treatment?
There currently is not a treatment for Sanfilippo Syndrome.  We do not know the exact incident rate of Sanfilippo type C. A few papers suggest 1 in 1.5 million births. By that measure there should be 4 babies born a year with Sanfilippo C. We only know of 20 cases in the U.S.


SSP:  What is the current research?
JJB along with our consortium: Helping Advance Neurodegenerative Disease Science (H.A.N.D.S.), made up of international medical research foundations, is struggling to keep the research funded. Our main research program is gene therapy, taking place in Manchester, UK. Since 2012, H.A.N.D.S. has collectively funded over $800,000 into this program. We are nearing clinical trial. We have one more pivotal study to complete before we can go to the Food and Drug Administration with our clinical trial protocol. Over the next two years H.A.N.D.S. plans to raise $500,000 to complete this study.



SSP: What is next/what can you share with us?
It has been a very exciting and progressive year for us. Our Natural History Study has finally been given approval by the National Institute of Health! If all goes as planned Jonah will be the first child to be enrolled in this study. Jonah and children like him will spend two days at Montiforie Childrens Hospital undergoing a battery of tests. From clinical tests to cognitive and behavioral exams, this data will help us gain a better understanding of the course of the disease.


The patient registry that JJB manages for all Sanfilippo subtypes has gained global exposure and the attention of pharmaceutical companies. This has helped us identify our global patient population, giving us a much better idea of incident rate and phenotype.


After clinical trial we will need investors to manufacture and commercialize our treatment. To help facilitate this partnership, we founded a virtual biotech, Phoenix Nest. The biotech puts us in a better position of attracting investors. http://www.phoenixnestbiotech.com/


The biotech also gives us the opportunity to apply for funding from the National Institute of Health. We have been very successful in winning these grants. The rub, these grants are for type B and D Jonah has type C. The NIH funding stipulates that the science happens in the United States. Our scientists working on type C live and work abroad. To get around this Phoenix Nest is in the process of licensing our gene therapy so that it belongs to a US based company. http://www.raredr.com/news/phoenix-nest-grant



SSP: What is needed NOW and how can we help support you?
We continue to raise funds to keep our research from slowing. With our ‘Heroes Among Us’ event on July 23rd we hope to raise the amount of $17,598.00 to pay for the production of our enzyme for our Sanfilippo type C gene therapy program.


For information on the event, please go to: Event Info

To make a donation, please go to: Donations

For more information on Jonah’s Just Begun organization, please go to: http://jonahsjustbegun.org/
0 Comments



Leave a Reply.

    Picture

    Jen Valu
    contributor + supermom

    Jen Valu is the mom of 2 small children who were SSP patients. She enjoys spending time with her family, especially the silly dance parties and creative time with her kids. Recently relocated to the suburbs, she misses Park Slope terribly but appreciates the sanity that has come along with space and a yard. "Embrace the crazy" is her motto.

    Archives

    July 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015

    Categories

    All
    About Us
    Back To School
    Cartoons & Kid Stuff
    Family Activities
    Food
    Health
    Holidays
    Interview
    Kindness
    Parenting Tips
    Park Slope
    Pediatric Care Advice
    Playgrounds In Brooklyn
    Sports
    SSP Values
    Summer
    Things To Do In Brooklyn

    RSS Feed

Stay connected with South Slope Pediatrics
Picture
Picture
Picture
Picture
Picture
Picture
Picture
South Slope Pediatrics,
​Dr. Hai Cao, MD
​501 5th Avenue, Park Slope, NY 11215
718.576.2450
​
Monday - 8am-6pm
Tuesday - 9am-6pm
Wednesday - 12 noon -7pm
Thursday - 9am-6pm
Friday - ​9am-5pm
Call SSP
Email SSP
  • Expecting? Book a Free Meet & Greet
  • 718.576.2450
  • SSP NEWS
  • Meet The Doctors + Team
  • Patient Portal
  • SSP Culture
  • SSP 4 Good
  • SSP Blog
  • Free SSP Classes
  • SSP LIVE Updates
  • Insurance
  • FAQs
  • Contact
  • SSP Jobs